These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23926104)

  • 1. Tripartite Motif-containing 33 (TRIM33) protein functions in the poly(ADP-ribose) polymerase (PARP)-dependent DNA damage response through interaction with Amplified in Liver Cancer 1 (ALC1) protein.
    Kulkarni A; Oza J; Yao M; Sohail H; Ginjala V; Tomas-Loba A; Horejsi Z; Tan AR; Boulton SJ; Ganesan S
    J Biol Chem; 2013 Nov; 288(45):32357-32369. PubMed ID: 23926104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALC1/CHD1L, a chromatin-remodeling enzyme, is required for efficient base excision repair.
    Tsuda M; Cho K; Ooka M; Shimizu N; Watanabe R; Yasui A; Nakazawa Y; Ogi T; Harada H; Agama K; Nakamura J; Asada R; Fujiike H; Sakuma T; Yamamoto T; Murai J; Hiraoka M; Koike K; Pommier Y; Takeda S; Hirota K
    PLoS One; 2017; 12(11):e0188320. PubMed ID: 29149203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1.
    Ahel D; Horejsí Z; Wiechens N; Polo SE; Garcia-Wilson E; Ahel I; Flynn H; Skehel M; West SC; Jackson SP; Owen-Hughes T; Boulton SJ
    Science; 2009 Sep; 325(5945):1240-3. PubMed ID: 19661379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment.
    Juhász S; Smith R; Schauer T; Spekhardt D; Mamar H; Zentout S; Chapuis C; Huet S; Timinszky G
    Sci Adv; 2020 Dec; 6(51):. PubMed ID: 33355125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Oncogenic Helicase ALC1 Regulates PARP Inhibitor Potency by Trapping PARP2 at DNA Breaks.
    Blessing C; Mandemaker IK; Gonzalez-Leal C; Preisser J; Schomburg A; Ladurner AG
    Mol Cell; 2020 Dec; 80(5):862-875.e6. PubMed ID: 33275888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP‑ribose) polymerase 1/2 inhibitors decrease the ubiquitination of ALC1 mediated by CHFR in breast cancer.
    Wang Y; Wang Y; Wang N; You L; Long F; Shao C; Wang Y; Wu J
    Oncol Rep; 2019 Oct; 42(4):1467-1474. PubMed ID: 31322269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The poly(ADP-ribose)-dependent chromatin remodeler Alc1 induces local chromatin relaxation upon DNA damage.
    Sellou H; Lebeaupin T; Chapuis C; Smith R; Hegele A; Singh HR; Kozlowski M; Bultmann S; Ladurner AG; Timinszky G; Huet S
    Mol Biol Cell; 2016 Dec; 27(24):3791-3799. PubMed ID: 27733626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP1 promotes nucleotide excision repair through DDB2 stabilization and recruitment of ALC1.
    Pines A; Vrouwe MG; Marteijn JA; Typas D; Luijsterburg MS; Cansoy M; Hensbergen P; Deelder A; de Groot A; Matsumoto S; Sugasawa K; Thoma N; Vermeulen W; Vrieling H; Mullenders L
    J Cell Biol; 2012 Oct; 199(2):235-49. PubMed ID: 23045548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin remodeler ALC1 prevents replication-fork collapse by slowing fork progression.
    Ooka M; Abe T; Cho K; Koike K; Takeda S; Hirota K
    PLoS One; 2018; 13(2):e0192421. PubMed ID: 29408941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and dynamics of the chromatin remodeler ALC1 bound to a PARylated nucleosome.
    Bacic L; Gaullier G; Sabantsev A; Lehmann LC; Brackmann K; Dimakou D; Halic M; Hewitt G; Boulton SJ; Deindl S
    Elife; 2021 Sep; 10():. PubMed ID: 34486521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the SNF2 family ATPase ALC1 by poly(ADP-ribose) in a stable ALC1·PARP1·nucleosome intermediate.
    Gottschalk AJ; Trivedi RD; Conaway JW; Conaway RC
    J Biol Chem; 2012 Dec; 287(52):43527-32. PubMed ID: 23132853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1.
    Lehmann LC; Hewitt G; Aibara S; Leitner A; Marklund E; Maslen SL; Maturi V; Chen Y; van der Spoel D; Skehel JM; Moustakas A; Boulton SJ; Deindl S
    Mol Cell; 2017 Dec; 68(5):847-859.e7. PubMed ID: 29220652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple roles for PARP1 in ALC1-dependent nucleosome remodeling.
    Ooi SK; Sato S; Tomomori-Sato C; Zhang Y; Wen Z; Banks CAS; Washburn MP; Unruh JR; Florens L; Conaway RC; Conaway JW
    Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34465625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene.
    Singh HR; Nardozza AP; Möller IR; Knobloch G; Kistemaker HAV; Hassler M; Harrer N; Blessing C; Eustermann S; Kotthoff C; Huet S; Mueller-Planitz F; Filippov DV; Timinszky G; Rand KD; Ladurner AG
    Mol Cell; 2017 Dec; 68(5):860-871.e7. PubMed ID: 29220653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD.
    Hewitt G; Borel V; Segura-Bayona S; Takaki T; Ruis P; Bellelli R; Lehmann LC; Sommerova L; Vancevska A; Tomas-Loba A; Zhu K; Cooper C; Fugger K; Patel H; Goldstone R; Schneider-Luftman D; Herbert E; Stamp G; Brough R; Pettitt S; Lord CJ; West SC; Ahel I; Ahel D; Chapman JR; Deindl S; Boulton SJ
    Mol Cell; 2021 Feb; 81(4):767-783.e11. PubMed ID: 33333017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells.
    Verma P; Zhou Y; Cao Z; Deraska PV; Deb M; Arai E; Li W; Shao Y; Puentes L; Li Y; Patankar S; Mach RH; Faryabi RB; Shi J; Greenberg RA
    Nat Cell Biol; 2021 Feb; 23(2):160-171. PubMed ID: 33462394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
    Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
    Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose) polymerases PARP1 and PARP2 modulate topoisomerase II beta (TOP2B) function during chromatin condensation in mouse spermiogenesis.
    Meyer-Ficca ML; Lonchar JD; Ihara M; Meistrich ML; Austin CA; Meyer RG
    Biol Reprod; 2011 May; 84(5):900-9. PubMed ID: 21228215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XPC-PARP complexes engage the chromatin remodeler ALC1 to catalyze global genome DNA damage repair.
    Blessing C; Apelt K; van den Heuvel D; Gonzalez-Leal C; Rother MB; van der Woude M; González-Prieto R; Yifrach A; Parnas A; Shah RG; Kuo TT; Boer DEC; Cai J; Kragten A; Kim HS; Schärer OD; Vertegaal ACO; Shah GM; Adar S; Lans H; van Attikum H; Ladurner AG; Luijsterburg MS
    Nat Commun; 2022 Aug; 13(1):4762. PubMed ID: 35963869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolytic processing of abasic sites underlies PARP inhibitor hypersensitivity in ALC1-deficient BRCA mutant cancer cells.
    Ramakrishnan N; Weaver TM; Aubuchon LN; Woldegerima A; Just T; Song K; Vindigni A; Freudenthal BD; Verma P
    Nat Commun; 2024 Jul; 15(1):6343. PubMed ID: 39068174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.